Abstract: An organic light-emitting display device includes: a plurality of pattern electrodes; a hole-transporting layer disposed on the plurality of pattern electrodes; a plurality of emission layers disposed on the hole-transporting layer and overlapping the plurality of pattern electrodes, respectively; a common electrode disposed on the emission layers; and a first auxiliary layer disposed between a first one of the pattern electrodes and a first one of the emission layers, wherein the first emission layer forms an interface with the hole-transporting layer or the first auxiliary layer, the interface having a hole barrier equal to or less than about 0.1 eV, wherein the hole-transporting layer and the first auxiliary layer have a hole mobility equal to or less than about 1.0×10?3 cm2/V·s.

Abstract: The present technology provides triazolopyridin-3-ones or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. The triazolopyridin-3-ones or their pharmaceutically acceptable salts exhibit inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).

Abstract: A multilayer capacitor may include a capacitor body including an active area including a plurality of dielectric layers, and a plurality of first and second internal electrodes, upper and lower cover layers disposed on upper and lower surfaces of the active area, and having first to six external surfaces; first and second external electrodes including first and second connection portions and first and second band portions, respectively; and a plurality of dummy electrodes disposed on the upper and lower cover layers with a dielectric layer interposed therebetween, and exposed through corners of the capacitor body, a portion of the plurality of dummy electrodes being disposed between the upper and lower surfaces of the capacitor body and the first and second band portions.

Abstract: Provided are a multilayer ceramic electronic component and a method for manufacturing the same, the multilayer ceramic electronic component including a ceramic body including a dielectric layer and an internal electrode, and an external electrode formed on an outer side of the ceramic body and electrically connected to the internal electrode, wherein the internal electrode includes a conductive metal and an additive, and the number of particles of the additive disposed per ?m2 of the internal electrode is in the range of 7 to 21, both inclusive.

Abstract: A method of driving a display panel in an organic light-emitting display device is provided. The method determines whether a single color image is displayed on the display panel or a multiple color image is displayed on the display panel, applies an initialization voltage, for initializing an anode of an organic light-emitting element included in a non-light-emitting pixel, to the anode of the organic light-emitting element included in the non-light-emitting pixel when the multiple color image is displayed on the display panel, and applies a lateral leakage prevention voltage that is higher than the initialization voltage to an anode of an organic light-emitting element included in an adjacent non-light-emitting pixel that is located within a reference distance from a light-emitting pixel when the single color image is displayed on the display panel.

Abstract: An electronic device is provided. The electronic device includes a first camera, a second camera, and a processor. The processor is configured to obtain a first image using the first camera and obtain a second image using the second camera, determine depth information corresponding to an external object, using the first image and the second image, when properties of the depth information meet a first specified condition, store the depth information in connection with the first image and the second image, and when the properties of the depth information meet a second specified condition, skip the storing of the depth information in connection with the first image and the second image.

Abstract: The present technology provides aryl or heteroaryl triazolone derivatives or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and the use thereof. The aryl or heteroaryl triazolone derivatives or their pharmaceutically acceptable salts exhibit selective inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).

Abstract: The present technology provides triazolone derivatives or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and the use thereof. The triazolone derivatives or their pharmaceutically acceptable salts exhibit selective inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).

Abstract: A display apparatus includes: a base substrate; a thin film transistor disposed on the base substrate and including an active pattern; an insulating layer disposed on the active pattern of the thin film transistor; a connection electrode disposed on the insulating layer, and electrically connected to the thin film transistor, wherein the connection electrode includes a curved wiring portion; a first via insulating layer covering the connection electrode; a first electrode disposed on the first via insulating layer; a light emitting layer disposed on the first electrode and at least partially overlapping the connection electrode; and a second electrode disposed on the light emitting layer.

Abstract: The present invention provides a quinazoline derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same and a use thereof. The quinazoline derivative or its pharmaceutically acceptable salt has a selective inhibitory activity against the phosphatidylinositol 3-kinase delta subunit, and therefore can be usefully applied for preventing or treating cancer, along with avoiding side effects such as lymphopenia-associated inflammatory responses.

Abstract: The present technology provides aryl or heteroaryl triazolone derivatives or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and the use thereof. The aryl or heteroaryl triazolone derivatives or their pharmaceutically acceptable salts exhibit selective inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).

Abstract: A method for situation awareness is provided. The method comprises: preparing a neural network trained by a learning set, wherein the learning set includes a plurality of maritime images and maritime information including object type information which includes a first type index for a vessel, a second type index for a water surface and a third type index for a ground surface, and distance level information which includes a first level index indicating that a distance is undefined, a second level index indicating a first distance range and a third level index indicating a second distance range greater than the first distance range; obtaining a target maritime image generated from a camera; and determining a distance of a target vessel based on the distance level index of the maritime information being outputted from the neural network which receives the target maritime image and having the first type index.

Abstract: In a self-detecting apparatus for workpiece-origin, a mobile machine tool having the self-detecting apparatus, a method for self-detecting the workpiece-origin, the self-detecting apparatus is equipped to the mobile machine tool and includes a vision sensor and a transmitting unit. The vision sensor obtains a point image marked to the workpiece, and detects a position of a workpiece-origin based on coincidence of focuses of the points. The transmitting unit provides an information obtained by the vision sensor to the mobile machine tool. The mobile machine tool is moved to the workpiece-origin, so as to coincide the focuses of the points, based on the provided point image obtained by the vision sensor.

Abstract: The present invention provides a quinazoline derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same and a use thereof. The quinazoline derivative or its pharmaceutically acceptable salt has a selective inhibitory activity against the phosphatidylinositol 3-kinase delta subunit, and therefore can be usefully applied for preventing or treating cancer, along with avoiding side effects such as lymphopenia-associated inflammatory responses.

Abstract: A method for learning a neural network performed by a computing means wherein the neural network receives a marine image and outputs information about a type and a distance of at least one object included in the marine image is provided. The method comprises: obtaining a marine image including a sea and an obstacle; obtaining a labelling data generated based on the marine image; obtaining an output data by using a neural network, wherein the neural network receives the marine image and outputs the output data; calculating an error value by using the labelling data and the output data; and updating the neural network based on the error value; wherein the labelling data and the output data are determined by a combination of information about a type and a distance of an object.

Abstract: The present technology provides triazolopyridin-3-ones or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. The triazolopyridin-3-ones or their pharmaceutically acceptable salts exhibit inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).

Abstract: The present technology provides aryl or heteroaryl triazolone derivatives or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and the use thereof. The aryl or heteroaryl triazolone derivatives or their pharmaceutically acceptable salts exhibit selective inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).

Abstract: A method of driving a display panel in an organic light-emitting display device is provided. The method determines whether a single color image is displayed on the display panel or a multiple color image is displayed on the display panel, applies an initialization voltage, for initializing an anode of an organic light-emitting element included in a non-light-emitting pixel, to the anode of the organic light-emitting element included in the non-light-emitting pixel when the multiple color image is displayed on the display panel, and applies a lateral leakage prevention voltage that is higher than the initialization voltage to an anode of an organic light-emitting element included in an adjacent non-light-emitting pixel that is located within a reference distance from a light-emitting pixel when the single color image is displayed on the display panel.

Abstract: The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.

Abstract: Methods and apparatuses for processing an image in an electronic device is provided. An image is obtained, and it is determined whether a specified shape exists in the image. When the specified shape exists in the image, a size of an area occupied by the specified shape in the image is calculated. It is determined whether the size of the area is greater than or equal to a first size. A specified effect is applied to the area, when the size of the area is greater than or equal to the first size.